Medical Device Innovation: Is a Code Necessary for Commercial Adoption?

Perspectives on Medical Reimbursement By JR Associates For some medical devices, more than one reimbursement pathway may be viable. And, as JR Associates recently explained to Medical Device Daily, that could be the case for the Dune MarginProbe – a system that delivers real-time breast cancer detection in the operating room, by helping surgeons assess…

Read More »

Coding For Hypothermia; Clarifying New Standards

Perspectives on Medical Reimbursement By JR Associates Reprinted from The Society of Critical Care Medicine Contributing Authors: Kim Norton* Managing Partner, Argenta Advisors Seattle, Washington, USA Judy Rosenbloom** President, JR Associates Reseda, California, USA George A. Sample, MD*** Washington Hospital Center Washington, D.C. In 2005, the American Heart Association published guidelines (Class IIa and IIb)…

Read More »

ASE Chooses Judy Rosenbloom As Reimbursement Consultant

Los Angeles—July 2005—The American Society of Echocardiography (ASE) today announced that JR Associates founder and president, Judy Rosenbloom, has been named Coding and Reimbursement Consultant. On an ongoing basis, Rosenbloom will provide strategic consulting for the ASE membership. A former ASE board member and Advocacy Committee member, Rosenbloom is deeply familiar with ASE’s structure and…

Read More »

Biomoda Readies Products To Assist Insurer Reimbursement

Outsourcing Partner Speeds Entry Into Commercial Cancer Detection and Treatment Market Albuquerque, N.M. — (Business Wire), June 30, 2004 — Biomoda, Inc. announced today that it has contracted with reimbursement consulting firm, JR Associates, to help advance Biomoda’s patented biopharmaceutical products. Primarily, JR Associates consultants will investigate the potential for securing positive coverage, coding, and payment by Medicare and commercial…

Read More »